Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Bone

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S8756-3282(98)00109-4PMID 9763149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Can biochemical markers predict bone loss at the hip and spine?: A 4-year prospective study of 141 early postmenopausal women

  2005cited by this paper
• Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus

  1997cited by this paper
• The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: A study of postmenopausal twins

  1996cited by this paper
• Genetic influence on bone turnover in postmenopausal twins.

  1996cited by this paper
• Association of bone mineral density with polymorphism of the estrogen receptor gene

  1996cited by this paper
• Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene

  1996cited by this paper
• Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain

  1995cited by this paper
• Bone density determinants in elderly women: A twin study

  1995cited by this paper
• Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene.

  1995cited by this paper
• Interleukin-1 and interleukin-1 receptor antagonist.

  1995cited by this paper
• Segregation analysis and variance components analysis of bone mineral density in healthy families

  1995cited by this paper
• Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover.

  1994cited by this paper
• Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus

  1994cited by this paper
• Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus.

  1994influential reference
• Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.

  1994cited by this paper
• Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis

  1994cited by this paper
• Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.

  1994cited by this paper
• Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study

  1994cited by this paper
• Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

  1994cited by this paper
• The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study.

  1993cited by this paper
• Changes in axial bone density with age: A twin study

  1993cited by this paper
• Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy.

  1993cited by this paper
• Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

  1993cited by this paper
• Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat

  1993cited by this paper
• Use of a risk factor and dietary calcium questionnaire in predicting bone density and subsequent bone loss at the menopause.

  1992cited by this paper
• Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene.

  1992cited by this paper
• Genetic factors in bone turnover.

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper
• Reduced bone mass in daughters of women with osteoporosis.

  1989cited by this paper
• Heritability of bone mass: a longitudinal study in aging male twins.

  1989cited by this paper
• Genetic determinants of bone mass in adults. A twin study.

  1987cited by this paper

• Deficiency of interleukin-1 receptor antagonist in mice differentially affects bone properties under different genomic backgrounds

  2024cites this paper
• Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases

  2022cites this paper
• A comprehensive overview on osteoporosis and its risk factors

  2018cites this paper
• Bivariate genome-wide association analyses identified genetic pleiotropic effects for bone mineral density and alcohol drinking in Caucasians

  2017cites this paper
• Pharmacogenetics and Metabolic Disease

  2016cites this paper
• Rôle du facteur de transcription PITX1 dans les pathogenèses de l'ostéoporose et des maladies parodontales

  2016cites this paper
• A novel association between IL1-Ra (receptor antagonist) gene polymorphism and T1DM in Al-Madina Al-Mounawra.

  2015cites this paper
• The genetics of osteoporosis.

  2015cites this paper
• The effect of FokI vitamin D receptor polymorphism on bone mineral density in Jordanian perimenopausal women

  2013cites this paper
• Comparison of interleukins IL-1β and IL-6 levels, bone mineral density (BMD) and bone metabolism (IBM) in menopausal women

  2012cites this paper
• Polymorphisms of the human IL-1 receptor antagonist gene and forearm bone mineral density in postmenopausal women

  2012cites this paper
• Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis

  2011cites this paper
• The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases

  2010cites this paper
• Genetic Polymorphism of Geranylgeranyl Diphosphate Synthase (GGSP1) Predicts Bone Density Response to Bisphosphonate Therapy in Korean Women

  2010cites this paper
• Association of Interleukin-1 Receptor Antagonist Gene Polymorphism With Response to Conservative Treatment of Lumbar Herniated Nucleus Pulposus

  2010cites this paper
• Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women

  2010cites this paper
• Συσχέτιση μεταξύ οστεοπόρωσης και περιοδοντίτιδας Association between osteoporosis and periodontitis

  2009cites this paper
• INTERLEUKIN-1A (IL-1A), IL-1B, IL-1RN, IL-6 AND IL-6R AND PROSTATE CANCER RISK IN AFRICAN AMERICAN AND CAUCASIAN MEN

  2009cites this paper
• Osteoporosis and its Association with Estrogen Receptor- alpha Gene Polymorphism in a population of Iranian Women Referring to Loghman Hospital

  2009cites this paper
• The Olympic textbook of medicine in sport

  2008cites this paper
• Cytokine Receptors in the Brain

  2008cites this paper
• Pathophysiology and Aging of Bone

  2008cites this paper
• Non‐HLA genetics and predicting outcome in HSCT

  2008cites this paper
• Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

  2007cites this paper
• Gene polymorphisms in primary biliary cirrhosis: association with the disease and hepatic osteopathy

  2007cites this paper
• IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression

  2007cites this paper
• Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women

  2007cites this paper
• Pharmacogenomics of osteoporosis: opportunities and challenges.

  2006cites this paper
• Bone mineral density-affecting genes in Africans.

  2006cites this paper
• Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging.

  2006cites this paper
• Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.

  2006cites this paper
• Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis.

  2005cites this paper
• Extrahepatic manifestations of cholestatic liver diseases

  2005cites this paper
• Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3h/HeJ inbred strains of mice. (2001).

  2005cites this paper
• Ovariectomy‐Induced Bone Loss Varies Among Inbred Strains of Mice

  2005cites this paper
• The G/C915 polymorphism of transforming growth factor β1 is associated with human longevity: a study in Italian centenarians

  2004cites this paper
• Susceptibility for Postmenopausal Osteoporosis: Interaction Between Genetic, Hormonal and Lifestyle Factors

  2004cites this paper
• Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women.

  2004cites this paper
• Effects of genetic and nutritional factors on bone mineral density in young adults.

  2004cites this paper
• Environmental factors and not genotype influence the plasma level of interleukin‐1 receptor antagonist in normal individuals

  2004cites this paper
• Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis.

  2004cites this paper
• Insulin-like growth factor I gene microsatellite repeat, collagen type Iα1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis

  2004cites this paper
• Identifying Genes Influencing Bone Mineral Density

  2004cites this paper
• Bases moleculares de la familia de la interleuquina-1

  2004cites this paper
• Interleukin-1β and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis

  2003cites this paper
• インターロイキン 1β にかかわる遺伝子多型と疾病リスク

  2003cites this paper
• Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip Arthroplasty

  2003cites this paper
• [Osteoporosis and cardiovascular disease--two sides of the same coin?].

  2003cites this paper
• Role of Transforming Growth Factor- 1 Gene Polymorphisms in Childhood Idiopathic Thrombocytopenic Purpura

  2003cites this paper
• Prevention and Treatment of Postmenopausal Osteoporosis

  2003cites this paper
• Role of transforming growth factor-beta 1 gene polymorphisms in childhood idiopathic thrombocytopenic purpura.

  2003cites this paper
• Searching for osteoporosis genes in the post-genome era: progress and challenges

  2003cites this paper
• Association of a Haplotype (196Phe/532Ser) in the Interleukin‐1‐Receptor‐Associated Kinase (IRAK1) Gene With Low Radial Bone Mineral Density in Two Independent Populations

  2003cites this paper
• The role of IL-1 gene cluster in longevity: a study in Italian population.

  2003cites this paper
• Association Between Bone Mineral Density and Candidate Genes in Different Ethnic Populations and Its Implications

  2003cites this paper
• Osteoporose und koronare Herzkrankheit – zwei Seiten der gleichen Münze?

  2003cites this paper
• Molecular and genetic mechanisms of osteoporosis: implication for treatment.

  2003cites this paper
• Molecular studies of identification of genes for osteoporosis: the 2002 update.

  2003cites this paper
• Association of a promoter haplotype (-1542G/-525C) in the tumor necrosis factor receptor associated factor-interacting protein gene with low bone mineral density in Japanese women.

  2003cites this paper
• Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis.

  2003cites this paper
• Changes in proinflammatory cytokine activity after menopause.

  2002cites this paper
• Genetics of osteoporosis.

  2002cites this paper
• Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures

  2002cites this paper
• 1,25 (OH)2 Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1α and Receptor Activator of NF-κB Ligand Production in Osteoblasts1

  2002cites this paper
• Chapter 10 Genetic and dietary factors in age-related bone loss

  2002cites this paper
• Genetic Determinants of Bone Mass and Osteoporotic Fracture

  2002cites this paper
• Mutational and Polymorphic Analysis of the Estradiol Receptor-a Gene in Men with Symptomatic Vertebral Fractures

  2002cites this paper
• Association of a single nucleotide variant in the human tumour necrosis factor alpha promoter region with decreased bone mineral density

  2002cites this paper
• Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-α gene polymorphisms in post-menopausal Mediterranean women

  2002cites this paper
• Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women.

  2002cites this paper
• Genetic control of IL‐1β bioactivity through differential regulation of the IL‐1 receptor antagonist

  2002cites this paper
• Two New Single‐Nucleotide Polymorphisms in the COL1A1 Upstream Regulatory Region and Their Relationship to Bone Mineral Density

  2002cites this paper
• Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density.

  2002cites this paper
• Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis

  2002cites this paper
• Influence of interleukin-1 receptor antagonist gene polymorphism on disease.

  2002cites this paper
• Cytokine imbalance in non-immunological chronic disease.

  2002cites this paper
• Predicting outcome in hematological stem cell transplantation.

  2002cites this paper
• Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1 and Receptor Activator of NF- B Ligand Production in Osteoblasts

  2002cites this paper
• Ethnic difference in contribution of alleles of the interleukin‐1 receptor antagonist gene to predisposition to osteoporosis

  2002cites this paper
• A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density

  2001cites this paper
• Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice

  2001cites this paper
• Role of genetic factors in the pathophysiology and management of osteoporosis

  2001cites this paper
• Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

  2001cites this paper
• The genetics of osteoporosis.

  2001cites this paper
• Pharmacogenetics of the vitamin D receptor and osteoporosis.

  2001cites this paper
• Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem.

  2001cites this paper
• Candidate Genes for Osteoporosis

  2001cites this paper
• Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice

  2001cites this paper
• Allelic variation at the interleukin 1β gene is associated with decreased bone mass in patients with inflammatory bowel diseases

  2001cites this paper
• GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro human skin explant model.

  2001cites this paper
• Osteoporotic Fractures Are Associated with an 86‐Base Pair Repeat Polymorphism in the Interleukin‐1‐Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin‐1β Gene

  2000cites this paper
• A TA Repeat Polymorphism in the Estrogen Receptor Gene Is Associated with Osteoporotic Fractures but Polymorphisms in the First Exon and Intron Are Not

  2000cites this paper
• Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women.

  2000cites this paper
• Genetic background of osteoporosis.

  2000cites this paper
• Update on the epidemiology of osteoporosis

  2000cites this paper
• Cytokines and Bone Loss in a 5‐Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin‐6 Receptor and Increases Interleukin‐1‐Receptor Antagonist: The Danish Osteoporosis Prevention Study

  2000cites this paper
• Genetic factors determine extent of bone loss in inflammatory bowel disease.

  2000cites this paper
• Association of a Polymorphism in the TNFR2 Gene with Low Bone Mineral Density

  2000cites this paper
• The genetics of osteoporosis. Future diagnostic possibilities.

  2000cites this paper
• Role of genetic factors in the pathogenesis of osteoporosis.

  2000cites this paper